Erdkang Pharmaceutical: Sodium Hydroxide API — “Notice of Approval for the Marketing Application of a Chemical Raw Material Drug”

Erkang Pharmaceutical announced that it recently received the "Notice of Approval for Marketing Authorization of Chemical Drug Substance" for sodium hydroxide API issued by the National Medical Products Administration.
Sodium hydroxide is a pH regulator. According to the query on the Public Platform for Registration Information of Excipients and Packaging Materials of the Center for Drug Evaluation of the National Medical Products Administration, as of the disclosure date of this announcement, there is a total of 1 valid registration number for sodium hydroxide API domestically. The result of the joint review and approval of this registration with the preparation is "A", and the above registered enterprise entity is the Company.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned